SCHEMBL7174644

SCHEMBL7174644

C=C(C)NCC(=O)Nc1c(C)ccc(O)c1C

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.39
PKM P14618 1/20 0.38
SMN1; SMN2 Q16637 3/20 0.36
MEN1 O00255 2/20 0.36
CYP1A2 P05177 2/20 0.36
CYP2C9 P11712 2/20 0.36
KMT2A Q03164 2/20 0.36
NFKB1 P19838 1/20 0.36
CYP2C19 P33261 1/20 0.36
MAPT P10636 3/20 0.35
KDM4E B2RXH2 1/20 0.35
GAA P10253 1/20 0.35
ALOX12 P18054 1/20 0.35
HTT P42858 1/20 0.35
HIF1A Q16665 1/20 0.35
LMNA P02545 2/20 0.34
SCN3A Q9NY46 2/20 0.34
HDAC3 O15379 1/20 0.34
HDAC4 P56524 1/20 0.34
HDAC1 Q13547 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8398430 0.81 CA1 (0.43) ALDH1A1SMN1; SMN2MEN1CYP1A2CYP2C9
SCHEMBL7171193 0.81 MEN1 (0.54) ALDH1A1PKMSMN1; SMN2MEN1CYP1A2
SCHEMBL7124281 0.79 TERT (0.42) ALDH1A1SMN1; SMN2MEN1CYP1A2CYP2C9
SCHEMBL7174642 0.77 KDM4E (0.43) ALDH1A1SMN1; SMN2MEN1CYP1A2CYP2C9
SCHEMBL8396114 0.77 ALDH1A1 (0.40) ALDH1A1PKMSMN1; SMN2MEN1CYP1A2
SCHEMBL10676572 0.76 ALDH1A1 (0.62) ALDH1A1PKMSMN1; SMN2MEN1CYP1A2
SCHEMBL6243924 0.72 ALDH1A1 (0.68) ALDH1A1PKMSMN1; SMN2MEN1KMT2A
SCHEMBL8393467 0.71 ALDH1A1 (0.42) ALDH1A1SMN1; SMN2MEN1CYP1A2CYP2C9
SCHEMBL8393470 0.68 POLB (0.38) ALDH1A1SMN1; SMN2MEN1CYP1A2CYP2C9
SCHEMBL25669864 0.66 ALDH1A1 (0.41) ALDH1A1PKMGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030040028-A1 Analgesic screening method and composition MILLER JAMES L (US) 2003-02-27 US disclosed
US-6489119-B1 SELECTING ANALGESIC AGENTS BASED ON THEIR SELECTIVE ABILITY TO BLOCK TETRODOTOXIN-INSENSITIVE SODIUM CHANNELS, PARTICULARLY IN COMPARISON TO BLOCKING TETRODOTOXIN-SENSITIVE SODIUM CHANNELS. ALSO DISCLOSED IS A NOVEL CLASS OF COMPOUNDS ELAN PHARMACEUTICALS, INC. 2002-12-03 US disclosed
EP-0915834-A1 METHOD AND COMPOSITIONS FOR PRODUCING ANALGESIA ELAN PHARMACEUTICALS, INC. (US) 1999-05-19 EP disclosed
WO-1997033860-A1 METHOD AND COMPOSITIONS FOR PRODUCING ANALGESIA NEUREX CORPORATION (US) 1997-09-18 WO disclosed